skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment

Journal Article · · mBio (Online)
 [1];  [2];  [1];  [1];  [2];  [2]; ORCiD logo [3]
  1. The Scripps Research Inst., La Jolla, CA (United States); La Jolla Institute for Immunology, La Jolla, CA (United States)
  2. The Scripps Research Inst., La Jolla, CA (United States)
  3. The Scripps Research Inst., La Jolla, CA (United States); La Jolla Institute for Immunology, La Jolla, CA (United States); Skaggs Institute for Chemical Biology, La Jolla, CA (United States)

The filoviruses are etiological agents of life-threatening hemorrhagic fever with high mortality rate and risk of potential outbreak. Among members of this family, the Ebola (EBOV), Sudan (SUDV), and Marburg (MARV) viruses are considered the most pathogenic for humans. The ebolavirus nucleoprotein (NP) is the most abundant protein in infected cells and is essential for viral transcription and replication; thus, it represents an attractive target for therapeutic intervention. Here, we present the structure of SUDV NP in complex with the amino-terminal portion of the phosphoprotein VP35 at 2.3 Å. This structure captures VP35 chaperoning SUDV NP in a monomeric and RNA-free state. This transient state has been proposed to be key to maintaining a pool of monomeric and RNA-free NPs prior to NP-NP polymerization and encapsidation of the viral RNA genome. This structure also reveals a newly visualized interaction between NP and VP35, a well-defined beta sheet that is not present in previous structures. Affinity binding assays demonstrate that this beta sheet is essential for maintaining the high-affinity interaction between VP35 and a hydrophobic pocket on SUDV NP, and electron microscopy indicates the importance of this binding interaction to the oligomeric state and assembly of NP in human cells. Complementary structure-directed mutagenesis identifies critical residues conserved across the filovirus family that could be targeted by broadly effective antivirals.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Contributing Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
OSTI ID:
1559324
Journal Information:
mBio (Online), Vol. 10, Issue 4; ISSN 2150-7511
Publisher:
American Society for MicrobiologyCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 6 works
Citation information provided by
Web of Science

References (45)

Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography journal February 2012
Overview of the CCP 4 suite and current developments journal March 2011
Identification and analysis of ebola virus messenger RNA journal April 1987
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers journal September 2011
The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes journal March 2013
Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex journal July 2015
Features and development of Coot journal March 2010
Structure of Nipah virus unassembled nucleoprotein in complex with its viral chaperone journal August 2014
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication journal April 2002
Morphology of Marburg Virus NP–RNA journal May 2002
P-Protein of Chandipura Virus Is an N-Protein-Specific Chaperone That Acts at the Nucleation Stage journal March 2004
Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome journal July 2013
Cryo-EM structure of the Ebola virus nucleoprotein–RNA complex at 3.6 Å resolution journal October 2018
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions journal April 2015
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. journal March 1985
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
The Ebola virus ribonucleoprotein complex: A novel VP30–L interaction identified journal March 2009
Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target journal February 2017
The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses journal August 2018
Structure and assembly of the Ebola virus nucleocapsid journal November 2017
Structure of the Vesicular Stomatitis Virus N0-P Complex journal September 2011
Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target journal July 2017
Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus journal June 2017
Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target journal December 2013
XDS journal January 2010
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012 journal August 2013
The L–VP35 and L–L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals journal July 2013
Identification of influenza A nucleoprotein as an antiviral target journal May 2010
Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association journal January 2007
Filovirus replication and transcription journal March 2007
The RNA synthesis machinery of negative-stranded RNA viruses journal May 2015
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. journal January 1995
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome journal December 2019
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation journal February 2021
Overview of the CCP4 suite and current developments. text January 2011
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus journal September 1993
The Assembly of Ebola Virus Nucleocapsid Requires Virion-Associated Proteins 35 and 24 and Posttranslational Modification of Nucleoprotein journal August 2002
Ebola Virus VP35 Antagonizes PKR Activity through Its C-Terminal Interferon Inhibitory Domain journal June 2009
The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR journal October 2006
Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK  and TBK-1 journal January 2009
Three of the Four Nucleocapsid Proteins of Marburg Virus, NP, VP35, and L, Are Sufficient To Mediate Replication and Transcription of Marburg Virus-Specific Monocistronic Minigenomes journal November 1998
Ebola Virus VP30-Mediated Transcription Is Regulated by RNA Secondary Structure Formation journal September 2002
Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells journal November 2014

Cited By (1)


Similar Records

Crystal Structure of the Marburg Virus VP35 Oligomerization Domain
Journal Article · Wed Nov 09 00:00:00 EST 2016 · Journal of Virology · OSTI ID:1559324

The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis
Journal Article · Tue Oct 18 00:00:00 EDT 2016 · PLoS Pathogens · OSTI ID:1559324

Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells
Journal Article · Sun Nov 15 00:00:00 EST 2015 · Virology · OSTI ID:1559324

Related Subjects